Scientists have discovered how E. coli bacteria target and degrade the well-known oncogene MYC, which is involved in many forms of cancer. The study is now published in Nature Biotechnology.
Cancer cells grow too fast, outcompete normal cells and spread to distant sites, where they cause metastases. Understanding what makes cancer cells so efficient and threatening is critically important and stopping them has always been the goal of cancer research. Early studies identified so-called ''oncogenes''; genes that that normally control cell growth but when mutated may be responsible for the creation of cancer cells and explain their competitive advantage.
The pleiotropic transcription factor MYC has been named ''the quintessential oncogene'' and is hyperactive in the majority of human cancers. Targeting MYC is therefore highly desirable. Still, finding c-MYC inhibitors for therapeutic use has been problematic and MYC itself has long been viewed as "undruggable".
Researchers have made the surprising discovery that uropathogenic E. coli deplete c-MYC protein from infected cells and tissues as a result of accelerated c-MYC protein degradation and attenuated MYC expression.
The discovery was made after observing that children with acute pyelonephritis have decreased MYC expression. By screening molecules released by the bacteria, Lon protease was identified as the main effector of MYC degradation, with selectivity for MYC.
The bacterial strategy was then translated into cancer therapy, showing prominent effects of Lon treatment in two different cancer models. Potent treatment effects on tumor growth and increased survival support the therapeutic potential of this molecule..
Surprisingly, the Lon protease was shown to mainly affect cells where MYC is overactive, suggesting limited toxicity. These findings have now been published in Nature Biotechnology
''The next step is to understand this "magical molecule" in more detail and to develop the project for future clinical trials''
https://www.nature.com/articles/s41587-020-00805-3
Bacterial degradation of the MYC oncogene
- 1,693 views
- Added
Edited
Latest News
Different brain Cells respo…
By newseditor
Posted 07 Jun
Key mechanism for maintaini…
By newseditor
Posted 06 Jun
How tumor stiffness alters…
By newseditor
Posted 06 Jun
Neural circuit involved in…
By newseditor
Posted 06 Jun
Signaling mechanism in live…
By newseditor
Posted 05 Jun
Other Top Stories
A noninvasive measure to identify dangerous blood vessel plaques
Read more
Bacteria found in Alzheimer's brains
Read more
Alternate energy switch in the cells identified!
Read more
New Harmless Radiopaque Glue to Seal Bleeding and Guide Surgery
Read more
How physical exercise prevents dementia
Read more
Protocols
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Clinical and CSF single-cel…
By newseditor
Posted 05 Jun
ChatGPT-assisted deep learn…
By newseditor
Posted 04 Jun
Turning the tide in aggress…
By newseditor
Posted 03 Jun
Mapping medically relevant…
By newseditor
Posted 01 Jun
Publications
YIPF3 and YIPF4 regulate au…
By newseditor
Posted 07 Jun
TRABD modulates mitochondri…
By newseditor
Posted 07 Jun
Cell-class-specific electri…
By newseditor
Posted 07 Jun
ARID1B controls transcripti…
By newseditor
Posted 07 Jun
Leveraging zebrafish to inv…
By newseditor
Posted 07 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar